Lilly to participate in Morgan Stanley 23rd Annual Global Healthcare Conference
Eli Lilly and Company (NYSE:LLY) will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference onSept. 8, 2025. Jacob VanNaarden, executive vice president and president of Lilly Oncology, and David Hyman, M.D., Lilly chief medical officer will take part in a fireside chat at 9:15 a.m., Eastern time. A live audio webcast will be […]